查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
亚太地区DNA甲基化检测技术市场：分析与预测（2023-2033）
市场调查报告书
商品编码
1556452

亚太地区DNA甲基化检测技术市场：分析与预测（2023-2033）

Asia-Pacific DNA Methylation Detection Technology Market: Analysis and Forecast, 2023-2033
出版日期: | 出版商: BIS Research | 英文 58 Pages | 商品交期: 1-5个工作天内

价格

2023年亚太地区DNA甲基化检测技术市场规模为4.436亿美元。

预计2023年至2033年该市场将以17.79%的复合年增长率成长，2033年达到22.806亿美元。这一增长可归因于生物技术和製药行业新兴企业数量的增加、学术机构之间合作的加强以及 DNA 甲基化检测技术作为表观遗传生物标记的广泛使用。市场提供各种工具、软体和消耗品。

主要市场统计数据
预测期 2023-2033
2023年评估 4.436 亿美元
2033 年预测 22.806 亿美元
复合年增长率 17.79%

由于该领域对个人化医疗和前沿基因组研究的需求不断增长，亚太地区DNA甲基化检测技术市场正在迅速扩大。 DNA甲基化是与癌症、神经系统疾病和心血管疾病等许多疾病相关的重要表观遗传修饰之一。 DNA 甲基化对于控制基因表现至关重要。随着表观遗传学在疾病诊断和治疗中的作用日益明确，人们越来越需要准确有效的DNA甲基化检测技术。

公共和商业部门都在大力资助与精准医学和基因组学相关的工作，尤其是在韩国、中国和日本等国家。此外，该地区慢性病的高发生率增加了对早期检测和标靶治疗的需求，进一步推动了DNA甲基化技术的采用。

随着次世代定序(NGS) 和高通量平台等技术的发展，DNA 甲基化分析的准确性和速度正在提高，学术机构和医疗专业人员也越来越负担得起。随着亚太地区成为生物医学创新中心，DNA 甲基化检测技术市场预计将显着成长。这对于个人化医疗的进步和改善患者的治疗效果至关重要。

本报告考察了亚太地区 DNA 甲基化检测技术市场，提供了市场概述、区域趋势以及参与该市场的公司概况。

目录

执行摘要

第一章 市场

  • 趋势：当前和未来的影响评估
  • 供应链概览
  • 研究发展回顾
  • 监管状况
  • 全球重大事件的影响分析 - COVID-19
  • 市场动态概览

第二章 区域

  • 区域概况
  • 促进因素和抑制因素
  • 亚太地区

第三章市场－竞争基准化分析与公司概况

  • 未来展望
  • 地理评估
    • Takara Bio Inc.

第四章调查方法

Product Code: BHP2267SS

Introduction to Asia-Pacific (APAC) DNA Methylation Detection Technology Market

The Asia-Pacific DNA methylation detection technology market was valued at $443.6 million in 2023 and is expected to reach $2,280.6 million by 2033, growing at a CAGR of 17.79% between 2023 and 2033. This growth can be ascribed to rising startups in the biotechnology and pharmaceutical industries, growing collaborations between academic institutions, and the growing use of DNA methylation detection technology as epigenetic biomarkers. The market offers a range of tools, software, and consumables.

Market Introduction

KEY MARKET STATISTICS
Forecast Period2023 - 2033
2023 Evaluation$443.6 Million
2033 Forecast$2,280.6 Million
CAGR17.79%

The market for DNA methylation detection technologies in Asia-Pacific is expanding rapidly due to the rising demand for personalized medicine and cutting-edge genomic research in the area. One important epigenetic modification that is linked to a number of diseases, including cancer, neurological disorders, and cardiovascular conditions, is DNA methylation. It is essential for regulating gene expression. Accurate and effective DNA methylation detection technologies are becoming more and more in demand as the role of epigenetics in disease diagnosis and treatment becomes increasingly clear.

Growing investments in biomedical research are driving the market's growth, especially in nations like South Korea, China, and Japan where both the public and commercial sectors are heavily funding efforts related to precision medicine and genomics. Furthermore, the region's high rate of chronic illnesses is increasing the demand for early detection and targeted therapies, further boosting the adoption of DNA methylation technologies.

The precision and speed of DNA methylation analysis are being improved by technological developments like next-generation sequencing (NGS) and high-throughput platforms, which are also making these technologies more affordable for academic institutions and medical professionals. The market for DNA methylation detection technology is expected to grow significantly as APAC establishes itself as a center for biomedical innovation. This will be crucial for the advancement of personalized medicine and better patient outcomes.

Market Segmentation

Segmentation 1: by Contry

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest-of-Asia-Pacific

How can this report add value to an organization?

Growth/Marketing Strategy: A strategic growth and marketing approach for the APAC DNA methylation detection technology market would involve positioning the company as a leader in innovative solutions that address the evolving needs of researchers, clinicians, and pharmaceutical partners. This would entail leveraging technological advancements to develop cutting-edge products with enhanced sensitivity, specificity, and scalability while also investing in comprehensive customer support, training programs, and collaborative partnerships to foster customer loyalty and drive market penetration. Furthermore, targeted marketing campaigns highlighting the clinical relevance, cost-effectiveness, and competitive advantages of the company's offerings would help to increase brand visibility, attract new customers, and expand market share in this rapidly growing and dynamic industry.

Competitive Strategy: Key players in the APAC DNA methylation detection technology market have been focusing on innovation, differentiation, and strategic collaborations to gain a competitive edge. By investing in research and development, companies can develop novel detection methods, improve assay sensitivity, and expand application areas. Differentiation through the development of proprietary technologies, customizable solutions, and value-added services can help companies stand out in a crowded market, strengthen market positions, acquire new technologies, and broaden product portfolios.

Table of Contents

Executive Summary

Scope and Definition

1 Markets

  • 1.1 Trends: Current and Future Impact Assessment
    • 1.1.1 Key Trends
    • 1.1.2 Bisulfite Conversion as a Gold Standard in the DNA Methylation Detection Technology Market
    • 1.1.3 Expansion of DNA Methylation Detection Technology in Clinical Research Applications
  • 1.2 Supply Chain Overview
    • 1.2.1 Value Chain Analysis
    • 1.2.2 Market Map
  • 1.3 Research and Development Review
    • 1.3.1 Patent Filing Trend (by Country, Company)
  • 1.4 Regulatory Landscape
  • 1.5 Impact Analysis for Key Global Events - COVID-19
  • 1.6 Market Dynamics Overview
    • 1.6.1 Market Drivers
      • 1.6.1.1 Increasing Adoption of DNA Methylation Detection Technology as Epigenetic Biomarkers
      • 1.6.1.2 Increasing Research and Development in Genomics and Epigenetics
      • 1.6.1.3 Technological Advancements in Detection Methods
    • 1.6.2 Market Restraints
      • 1.6.2.1 Complexity in Data Interpretation of DNA Methylation Data
      • 1.6.2.2 High Cost of DNA Methylation Detection Instruments and Various Kits and Assays
    • 1.6.3 Market Opportunities
      • 1.6.3.1 DNA Methylation Detection Technology as an Early Disease Diagnostic Tool
      • 1.6.3.2 Expansion of DNA Methylation Detection in Emerging Geographies

2 Regions

  • 2.1 Regional Summary
  • 2.2 Drivers and Restraints
  • 2.3 Asia-Pacific
    • 2.3.1 Regional Overview
    • 2.3.2 Driving Factors for Market Growth
    • 2.3.3 Factors Challenging the Market
    • 2.3.4 China
    • 2.3.5 Japan
    • 2.3.6 India
    • 2.3.7 Australia
    • 2.3.8 South Korea
    • 2.3.9 Rest-of-Asia-Pacific

3 Markets - Competitive Benchmarking & Company Profiles

  • 3.1 Next Frontiers
  • 3.2 Geographic Assessment
    • 3.2.1 Takara Bio Inc.
      • 3.2.1.1 Overview
      • 3.2.1.2 Top Products/Product Portfolio
      • 3.2.1.3 Top Competitors
      • 3.2.1.4 Key Personnel
      • 3.2.1.5 Analyst View

4 Research Methodology

  • 4.1 Data Sources
    • 4.1.1 Primary Data Sources
    • 4.1.2 Secondary Data Sources
    • 4.1.3 Data Triangulation
  • 4.2 Market Estimation and Forecast

List of Figures

  • Figure 1: DNA Methylation Detection Technology Market (by Region), $Billion, 2022, 2026, and 2033
  • Figure 2: Number of Methylation Analysis Publications, in Thousands, 2002-2020
  • Figure 3: Number of Commercially Available Methylation Tests (by Application Areas)
  • Figure 4: DNA Methylation Detection Technology Market, Recent Developments
  • Figure 5: Supply Chain and Risks within the Supply Chain
  • Figure 6: DNA Methylation Detection Technology Market (by Country), January 2021-December 2023
  • Figure 7: DNA Methylation Detection Technology Market (by Year), January 2021-December 2023
  • Figure 8: Impact of COVID-19 on DNA Methylation Detection Technology
  • Figure 9: Impact Analysis of Market Navigating Factors, 2022-2033
  • Figure 10: Advantage of DNA Methylation as Epigenetic Biomarkers
  • Figure 11: Analyzing the Differences: IColocomf vs. FIT and Colonoscopy
  • Figure 12: Evolution in Next-Generation Sequencing (NGS)Techniques for DNA Methylation Analysis, 2005-2021
  • Figure 13: Factors Responsible for Complexity in Data Interpretation
  • Figure 14: Pricing Analysis of Major DNA Methylation Detection Kits and Assays
  • Figure 15: Startups Working in Epigenomics Research
  • Figure 16: China DNA Methylation Detection Technology Market, $Million, 2022-2033
  • Figure 17: Japan DNA Methylation Detection Technology Market, $Million, 2022-2033
  • Figure 18: Australia DNA Methylation Detection Technology Market, $Million, 2022-2033
  • Figure 19: South Korea DNA Methylation Detection Technology Market, $Million, 2022-2033
  • Figure 20: Rest-of-Asia-Pacific DNA Methylation Detection Technology Market, $Million, 2022-2033
  • Figure 21: Strategic Initiatives, 2019-2023
  • Figure 22: Share of Strategic Initiatives, 2019-2023
  • Figure 23: Data Triangulation
  • Figure 24: Top-Down and Bottom-Up Approach
  • Figure 25: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: DNA Methylation Detection Technology Market, Opportunities
  • Table 3: Market Share of Key Companies, 2022
  • Table 4: DNA Methylation Detection Technology Market, Product Benchmarking
  • Table 5: Examples of Increasing Research in the DNA Methylation Detection Technology Industry
  • Table 6: Key Companies and Technological Advancements, 2019-2023
  • Table 7: DNA Methylation Detection Technology Market (by Region), $Million, 2022-2033
  • Table 8: India DNA Methylation Detection Technology Market, $Million, 2022-2033
  • Table 9: Company Market Share, 2022